INS and diabetes mellitus: Further, evaluating treatment for diabetes, no differences in oral hypoglycemic treatment (respectively 91% Vs 89%, p=0,831) or insulin treatment (respectively 18% Vs 6%, p=0.1) was found between LADA with and without intracellular immunoreactivity.